Great progress and what should have been done 12 months ago.
Assuming Matt keeps pulling costs out of running the plant and getting the staff and admin costs down, we should see revenue over 1000K and the burn rate under a million in the next quarter.
Matt is obviously feeing comfortable on cost side given the more than 3-fold lift in advertising and marketing spend for next quarter.
- Forums
- ASX - By Stock
- Ann: Appendix 4C - quarterly
RAN
range international limited
Add to My Watchlist
0.00%
!
0.2¢

Great progress and what should have been done 12 months ago....
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.878M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 4938403 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 2070004 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 4938403 | 0.002 |
23 | 50444769 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 2070004 | 6 |
0.004 | 1155263 | 3 |
0.005 | 2454695 | 3 |
0.006 | 2185526 | 2 |
0.007 | 244444 | 1 |
Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
Featured News
RAN (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online